Diabetes Drug May Treat Ovarian Cancer

Diabetic patients with ovarian cancer who took the drug metformin for their diabetes had a better survival rate than patients who did not take it. When Mayo Clinic researchers analyzed factors such as the patients’ body mass index, the severity of the cancer, type of chemotherapy and quality of surgery, they found that patients taking metformin were nearly four times likelier to survive, compared with those not taking the medication. The results may pave the way for using metformin in large-scale randomized trials in ovarian cancer.      Click here for news release